What is J code J0897?
What is J code J0897?
J0897. INJECTION, DENOSUMAB, 1 MG.
What is the administration code for Prolia?
CPT® 96401 is valued at approximately $75, and CPT® 96372 at approximately $25 (Medicare fee schedule).
What is the administration code for J0894?
HCPCS Code Details – J0894
| HCPCS Level II Code Drugs administered other than oral method, chemotherapy drugs Search | |
|---|---|
| HCPCS Code | J0894 |
| Description | Long description: Injection, decitabine, 1 mg Short description: Decitabine injection |
| HCPCS Modifier1 | |
| HCPCS Pricing indicator | 51 – Drugs |
What is the J code for ferumoxytol?
CPT feraheme j code , Q0138, Q0139, J1750, 11756, J2916. Ferumoxytol is covered for the FDA-approved ages – 18 years of age and older. 3. iron deficiency anemia in adult beneficiaries who are peritoneal dialysis dependent with chronic kidney disease (PDD-CKD).
What is the CPT code for denosumab Prolia?
Instead, the administration of the following drugs in their subcutaneous forms should be billed using CPT code 96372, (therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular). Generic Name Trade Name HCPCS Code denosumab Prolia/Xygeva® J0897
What is the ICD 10 code for Prolia 60 mg?
Prolia® (denosumab) 60 mg HCPCS code (J-code): J0897 (injection, denosumab 1 mg)2 NDC number: 55513-0710-013 Use of a 60 mg prefilled syringe of Prolia® is reported as:
What is Prolia used to treat?
Prolia® is a prescription medicine used to treat osteoporosis (thinning and weakening of bone) in women after menopause who are at high risk for fracture, meaning women who have had a fracture related to osteoporosis, or who have multiple risk factors for fracture. [1] You may ask, why would this drug ever be reported using 96401?
Is CPT® 96401 correct to report Prolia® administration?
My client had asked if CPT® 96401 Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic or CPT® 96372 Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular is correct to report administration of Prolia®.
